These growth stocks are still cheap, despite the S&P 500 being near a record high price-to-sales valuation

The article notes that while the S&P 500’s forward P/E has fallen meaningfully over the past year, its forward price-to-sales ratio is near a 20-year high—an apparent warning for valuation risk. It suggests potential opportunities remain in “growth stocks” whose price-to-earnings ratios have improved as corporate profits have surged. Overall, the message is cautiously negative on broad-market valuation but not a sector-wide catalyst.

Analysis

The key setup is not “market expensive” so much as “index-level multiple masking a dispersion trade.” When sales are richly priced but earnings are still growing, the market is implicitly underwriting continued margin expansion; that leaves the broad index vulnerable if revenue growth decelerates even modestly, because the de-rating can come from the top line rather than a profit recession.

The beneficiaries are high-ROIC, cash-generative growth franchises that can grow without needing constant multiple support. That argues for large-cap software/semis/internet leaders with durable free cash flow and balance-sheet strength; they can absorb higher discount rates and still compound. The losers are revenue-heavy, low-margin growth names and speculative duration assets where a small slowdown in bookings or a higher-rate backdrop forces rapid multiple compression.

Near term, the catalyst path is mostly macro: real yields, breadth, and the next two earnings seasons. If rates stay sticky or guidance broadens down, the market will stop paying up for sales and start rewarding conversion quality; if inflation cools and rates fall, the index-level sales multiple can remain elevated longer than bears expect. The contrarian miss is that a high P/S does not automatically mean “bubble” when mega-cap margins are structurally higher than history, but it does mean investors should prefer single-name selection over passive beta.

Tradeable expression is dispersion, not outright index shorting. The cleanest risk/reward is long profitable growth versus short speculative growth; the thesis is invalidated if breadth improves and unprofitable growth re-accelerates on easier financial conditions.

Key Decisions for Investors

• Long XLK / short ARKK for the next 1-3 months: express the quality-vs-speculation spread as elevated rates punish low-conviction revenue growth; best entry on market-strength, with thesis fading if real yields fall materially.
• Accumulate a basket of high-FCF growth leaders on pullbacks (MSFT, GOOGL, AVGO, META) over 2-6 weeks: upside comes from multiple durability plus earnings compounding; risk/reward is attractive versus the index because these names can grow EPS faster than sales.
• Avoid adding to low-margin, revenue-heavy growth names into rallies; use them as shorts or underweights if 2Q/3Q guidance shows even minor deceleration, since valuation compression will be more violent than the earnings miss.
• Set an alert on 10Y real yields and the next earnings revision breadth data: if real yields drop and revisions turn upward, the valuation warning weakens and the dispersion trade should be reduced quickly.
• If wanting a simpler hedge, short RSP against QQQ on strength: the thesis is that passive equal-weight will underperform if index multiples are being held up by a narrow set of profitable megacaps.